$IDDR Read this latest Press Release IDdriven, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
$IDDR Read this latest Press Release


IDdriven, Inc. Announces Oxford Computer Group Has Funded and Developed an Interface Software to Connect the Company's IDaaS Solution With Microsoft's Identity Manager Software Program
Marketwired IDdriven
June 13, 2016 2:33 PM



SACRAMENTO, CA--(Marketwired - Jun 13, 2016) - IDdriven, Inc. (OTCQB: IDDR), developer of the new breed of Identity and Access Management solutions, is pleased to announce that Oxford Computer Group (OCG) has funded and developed a proprietary interface software to be used to seamlessly connect the Company's IDaaS solution with Microsoft's Identity Manager Software program. Last week, IDdriven, Inc. announced a channel partner and distribution agreement with Oxford Computer Group for the Company's signature (IDaaS) Solution.

OCG sees great value in connecting the two software programs and took it upon themselves to develop this proprietary interface software at their own expense. This connector brings a solution for hybrid application landscape and enables customers to move from on-premises to a cloud application landscape. With such a connecting software now in place, OCG can begin selling IDdriven's IDaaS solution to their client network of 1000s of companies, many of which are blue-chip and/or well-known global brands.

With OCG's connector and the IDdriven cloud connectors, the full integration with MSFT O365 and Azure AD is feasible for all their customers. Customers with an O365, Enterprise Mobility Suite or Azure Premium subscription, highly benefit from the total solution OCG can bring to market.

Both OCG and IDdriven believe the new interface software will also allow them to start rolling out the IDaaS solution to the enormous number of companies worldwide currently using Microsoft's Identity Manager Software program. The IDaaS solution is seen as an asset and selling tool when offering clients a management software package. OCG has already completed numerous implementations for Microsoft and has received Microsoft's Partner of the Year Award seven times.

IDdriven Inc. CEO Arend Verweij said, "OCG is one of the premier identity access, cloud, and mobile device management solutions companies in the world. They have been in business for over 30 years and have a robust distribution network. Having them build entirely new interface software specifically to connect our IDaaS solution with Microsoft's Identity Management Software program gives us great confidence in both our product and direction as a company. Our IDaaS solution couples with Microsoft's software to provide users with a complete identity access, cloud, and mobile device management solution unmatched by any of our competitors. This new interface software gives IDdriven a clear competitive advantage and positions us to capitalize on a fast-growing market."

About Oxford Computer Group

Oxford Computer Group has been at the forefront of information technology for more than 30 years, and in the identity and access management business since 2002. It has received the prestigious Microsoft's Partner of the Year award seven times in 1991, 1993, 2000, 2008, 2013, 2014, and most recently in 2015 for enterprise mobility, and was named a finalist for the past ten years (www.oxfordcomputergroup.com).

About IDdriven, Inc. (IDDR)

IDdriven is at the forefront of the new breed of Identity Management and Access Governance solutions. Taking the complexity and upfront costs out of implementation, IDdriven is trusted to protect a company's most vulnerable assets. Founded in 2013, IDdriven is headquartered in Sacramento, California. To learn more, visit: www.IDdriven.com.

Forward-Looking Statement Disclosure

This news release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond IDdriven's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) commercialization of our software programs, (ii) development and protection of our intellectual property, (iii) industry competition, (iv) we may need to raise capital to meet business requirements. More detailed information about IDdriven and the risk factors that may affect the realization of forward looking statements is contained in our filings with the Securities and Exchange Commission which are available on our website and at www.sec.gov. IDdriven assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Contact:
IDdriven Company Contact
E: investors@IDdriven.com
T: 415.226.7773
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading